Latest papers

Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.

PharmaPlant: the new frontier in vaccines. Forward.

A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.

Plant glycans: friend or foe in vaccine development?

Development of plant-based mucosal vaccines against widespread infectious diseases.

Transient expression systems for plant-derived biopharmaceuticals.

Plant-made immunogens and effective delivery strategies.

Chloroplasts as expression platforms for plant-produced vaccines.

Human papillomavirus vaccines in plants.

Plant-based vaccines against human hepatitis B virus.

Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.

Current status of plant-made vaccines for veterinary purposes.

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization.

Plant-derived vaccines and other therapeutics produced in contained systems.

Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Postexposure treatment of Marburg virus infection.

Salivary gland thrombostasin isoforms differentially regulate blood uptake of horn flies fed on control- and thrombostasin-vaccinated cattle.

Type I interferons mediate the innate cytokine response to recombinant fowlpox virus but not the induction of plasmacytoid dendritic cell-dependent adaptive immunity.

Virus-like particles as particulate vaccines.

Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen.